Alcolase
Alcolase85
About
What does Alcolase do?
Alcolase is a Danish biotech startup developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream. This technology is specifically aimed at individuals with ALDH2 deficiency, a genetic variant common in East Asia that impairs alcohol metabolism, leading to adverse reactions and increased health risks. The company's proprietary encapsulation technology protects enzymes from stomach acid, allowing them to remain active in the stomac…
What is Alcolase's revenue?
StartupHub estimates Alcolase's annual revenue at $934K (range $472K to $3.3M, 69% confidence), based on comparable companies in the sector.
Where is Alcolase headquartered?
Alcolase is headquartered in Copenhagen, Denmark.
When was Alcolase founded?
Alcolase was founded in 2021.
What industry does Alcolase operate in?
Alcolase operates in Biotechnology, Health, Pharmaceuticals, Drug Delivery, Biotech, HealthTech.
How many employees does Alcolase have?
Alcolase has approximately 8 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.